<DOC>
	<DOCNO>NCT01285999</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness PROMUS™ Element™ Everolimus-Eluting Coronary Stent System treatment subject China single de novo atherosclerotic coronary artery lesion .</brief_summary>
	<brief_title>A Prospective , Randomized , Multicenter Trial Assess Everolimus-Eluting Coronary Stent System ( PROMUS™ Element™ ) Treatment Single De Novo Coronary Artery Lesion</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Clinical Subject must age 18 75 year Subject ( legal guardian ) understand trial requirement treatment procedure provide write informed consent trial specific test procedure perform Subject eligible percutaneous coronary intervention ( PCI ) Subject symptomatic coronary artery disease document silent ischemia Subject acceptable candidate coronary artery bypass grafting ( CABG ) Subject leave ventricular ejection fraction ( LVEF ) ≥30 % measure within 60 day prior enrollment Subject willing comply protocolrequired followup evaluation Angiographic Target lesion must de novo lesion locate native coronary artery visually estimate reference vessel diameter ( RVD ) ≥2.50 mm ≤ 4.00 mm . Target lesion length must measure &lt; 38 mm ( visual estimate ) Target lesion must visually estimate stenosis ≥50 % &lt; 100 % Thrombolysis Myocardial Infarction ( TIMI ) flow &gt; 1 . Target lesion must successfully predilated . Subject clinical symptom and/or electrocardiogram ( ECG ) change consistent acute MI Subject unstable angina recent MI ( within 1 week ) must creatine kinase ( CK ) / creatine kinasemyoglobin band ( CKMB ) troponin document prior procedure exclude follow criterion meet time index procedure : CK MB &gt; 2× upper limit normal ( ULN ) , subject exclude regardless CK Total . If CK Total &gt; 2× ULN , either CKMB troponin must draw subject exclude either CKMB troponin abnormal . If neither CK Total CK MB drawn troponin , subject exclude troponin &gt; 1× ULN subject least one following : Subject ischemic symptom ECG change indicative ongoing ischemia ( e.g. , &gt; 1 mm stent thrombosis ( ST ) segment elevation depression consecutive lead new left bundle branch block [ LBBB ] ) Development pathological Q wave ECG ; Imaging evidence new loss viable myocardium new regional wall motion abnormality Note : Subjects recent MI unstable angina must still CK/CKMB troponin drawn prior index procedure . However , result subject need available prior index procedure exclusion criterion base laboratory study . Subject receive organ transplant wait list organ transplant Subject receiving schedule receive chemotherapy within 30 day index procedure Subject receive oral intravenous immunosuppressive therapy ( Note : use inhale steroid exclude subject ) know life limit immunosuppressive autoimmune disease ( e.g. , human immunodeficiency virus , systemic lupus erythematosus ; Note : include diabetes mellitus ) Subject receive chronic ( ≥72 hour ) anticoagulation therapy ( e.g. , heparin , coumadin ) indication acute coronary syndrome Subject platelet count &lt; 100,000 cells/mm3 &gt; 700,000 cells/mm3 Subject white blood cell ( WBC ) count &lt; 3,000 cells/mm3 Subject document suspect liver disease , include laboratory evidence hepatitis Subject dialysis serum creatinine level &gt; 2.0 mg/dL Subject active peptic ulcer disease , active gastrointestinal ( GI ) bleed , bleed diathesis coagulopathy refuse transfusion Subject cerebrovascular accident ( CVA ) transient ischemic attack ( TIA ) within past 6 month , permanent neurologic defect may cause noncompliance protocol Target vessel ( include side branch ) treat type PCI ( e.g. , balloon angioplasty , stent , cut balloon , atherectomy ) within 12 month prior index procedure Target vessel treat within 10 mm proximal distal target lesion ( visual estimate ) type PCI ( e.g. , balloon angioplasty , stent , cut balloon , atherectomy ) time prior index procedure Nontarget vessel treat type PCI ( e.g. , balloon angioplasty , stent , cut balloon , atherectomy ) within 24 hour prior index procedure Planned actual target vessel treatment unapproved device , directional rotational coronary atherectomy , laser , cut balloon , transluminal extraction catheter immediately prior stent placement Planned PCI CABG index procedure Subject previously treat time coronary intravascular brachytherapy Subject know allergy study stent system protocolrequired concomitant medication ( e.g. , everolimus , paclitaxel structurally related compound ; fluoropolymers ; thienopyridines aspirin ; contrast ; acrylic ; stainless steel ; platinum ; chromium ; nickel ; iron ; tungsten ) adequately premedicated Subject serious medical illness ( e.g. , cancer , congestive heart failure ) may reduce life expectancy le 12 month Subject current problem substance abuse ( e.g. , alcohol , cocaine , heroin , etc . ) Subject plan procedure may cause noncompliance protocol confound data interpretation Subject participate another investigational drug device clinical trial reach primary endpoint intend participate another investigational drug device clinical trial within 12 month index procedure Subject know intention procreate within 12 month index procedure ( Women childbearing potential sexually active must agree use reliable method contraception time screen 12 month index procedure . ) Subject woman pregnant nursing ( A pregnancy test must perform within 7 day prior index procedure woman child bear potential . ) Subject 1 lesion require treatment index procedure Angiographic Target lesion meet follow criterion : Left main location Located within 5 mm origin leave anterior descending ( LAD ) coronary artery leave circumflex ( LCX ) coronary artery Right Coronary Artery ( RCA ) visual estimate Located within saphenous vein graft arterial graft Will access via saphenous vein graft arterial graft Involves side branch ≥2.0 mm diameter visual estimate Involves side branch &lt; 2.0 mm diameter visual estimate require treatment TIMI flow 0 ( total occlusion ) TIMI flow 1 prior guide wire cross Excessive tortuosity proximal within lesion Excessive angulation proximal within lesion Target lesion and/or target vessel proximal target lesion ismoderately severely calcified visual estimate Restenotic previous intervention Thrombus , possible thrombus , present target vessel Target lesion cover single study stent ( unplanned bailout stenting allow ) Subject unprotected leave main coronary artery disease ( &gt; 50 % diameter stenosis ) Subject protect leave main coronary artery disease ( &gt; 50 % diameter stenosis LMCA bypass graft [ ] leave coronary artery ) target lesion LAD LCX Subject additional clinically significant lesion ( ) intervention within 12 month index procedure may require</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>